Status:
COMPLETED
Cortisone Treatment for the Prevention of Postoperative Pancreatitis and Pancreatitis-induced Complications After Pancreaticoduodenectomy and Distal Pancreatic Resection
Lead Sponsor:
Tampere University Hospital
Conditions:
Postoperative Complications
Postoperative Pancreatitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this randomized, placebo-controlled trial is to investigate whether postoperative pancreatitis and other immediate complications after pancreaticoduodenectomy or distal pancreatic resec...
Eligibility Criteria
Inclusion
- Pancreaticoduodenectomy and distal pancreatectomy patients in Tampere University Hospital
Exclusion
- Patients with an ongoing cortisone treatment
- Cefuroxime allergy
- Chronic pancreatitis
Key Trial Info
Start Date :
February 1 2011
Trial Type :
INTERVENTIONAL
End Date :
January 1 2017
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01460615
Start Date
February 1 2011
End Date
January 1 2017
Last Update
November 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tampere University Hospital
Tampere, Finland, 33520